Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by Roussel Uclaf SA. View detailed product information, certifications, and sourcing options for each API. Connect with Roussel Uclaf SA for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: France
Supplier Description: Roussel Uclaf S.A. was a major French pharmaceutical company and one of the key predecessors of today’s global pharmaceutical giant Sanofi. The company played a pivotal role in pharmaceutical innovation, most notably as the original developer of mifepristone (RU-486), the widely known abortion pill. Roussel Uclaf was a leading French pharmaceutical firm until its acquisition by Hoechst AG, a German chemical and pharmaceutical company, in 1997. After acquisition, Roussel Uclaf’s pharmaceutical operations were merged into Hoechst Marion Roussel (HMR) in the United States. HMR later merged with Rhône-Poulenc in 1999 to form Aventis, which subsequently merged with Sanofi-Synthélabo in 2004, creating Sanofi-Aventis (now Sanofi). Roussel Uclaf’s agrochemical division was transferred to Hoechst Schering AgrEvo GmbH in 1994, which later became part of Bayer CropScience. - Show More
